| 发明名称 |
MARKERS FOR IDENTIFYING BREAST CANCER TREATMENT MODALITIES |
| 摘要 |
The present invention includes methods for identifying patients who will be resistant to endocrine therapy during breast cancer treatment and determining patient outcome. The methods are based on identifying increased expression of PBX1, or the cistrome signature associated therewith, in breast tissue samples. |
| 申请公布号 |
US2014011695(A1) |
申请公布日期 |
2014.01.09 |
| 申请号 |
US201213985470 |
申请日期 |
2012.02.15 |
| 申请人 |
LUPIEN MATHIEU;MAGNANI LUCA;TRUSTEES OF DARTMOUTH COLLEGE |
发明人 |
LUPIEN MATHIEU;MAGNANI LUCA |
| 分类号 |
C12Q1/68;G01N33/574 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
